Brief: Klaria Q3 2021 Loss At SEK 15.2 Mln
Oct 28 (Reuters) - Klaria Pharma Holding AB (publ)
KLAR.ST :
* KLARIA INTERIM REPORT Q3 2021
* Q3 NET SALES AMOUNTED TO 0.0 MSEK (0.0 MSEK)
* Q3 NET SALES AMOUNTED TO 0.0 MSEK (0.0 MSEK)
* Q3 LOSS AFTER TAX AMOUNTED TO -15.2 MSEK (-13.3 MSEK)
Source text for Eikon: ID:nWkr9cG7Qj
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement